Reducing Blood Pressure in Mid-life Adult Binge Drinkers
Alcohol Drinking, Binge Drinking, Blood Pressure
About this trial
This is an interventional treatment trial for Alcohol Drinking focused on measuring Exercise training, High-intensity interval training, Midlife adults, Middle-aged, Microvascular function, Sympathetic nerve activity
Eligibility Criteria
Inclusion Criteria:
- Men and women (50-64 years of age) who do not drink alcohol, who drink at moderate levels, or who binge drink
- Female subjects will be postmenopausal (i.e., cessation of menses for ≥1 yr).
- Subjects who can speak and understand English.
Exclusion Criteria:
- a history of diabetes, cardiovascular disease, liver, or renal disease
- current or history of smoking and illicit drug use
- blood pressure ≥160/100 mm Hg
- other known traditional cardiovascular disease risks: obesity (BMI≥35 kg/m2), or hyperlipidemia (total cholesterol>230 mg/dl and/or LDL cholesterol>160 mg/dl)
- active infection (in the past 2 months)
- a history of seizures, cancer, or inflammatory disease (i.e., gout or rheumatoid)
- unstable body weight (>5% change during the past 6 months)
- regular aerobic exercise training (i.e., they engage in 30 min of structured aerobic exercise at least 3 times per week)
- current use of hormone replacement therapy (i.e., estrogen, progesterone, and testosterone)
Sites / Locations
- University of Texas at ArlingtonRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Exercise Group
Non-exercise Group
Alcohol abstainer/moderate drinker group
Binge drinkers who have been assigned to exercise group will receive baseline assessment, 8-week exercise training plus alcohol abstinence intervention, and post-intervention assessment.
Binge drinkers who have been assigned to non-exercise group will receive baseline assessment, 8-week alcohol abstinence intervention, and post-intervention assessment.
Alcohol abstainer/moderate drinker will complete baseline assessment only and will not receive any intervention.